CA 33084/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1984	2
1985	4
1986	5
1987	1
1988	4
1989	4
1990	1
1991	2
1992	1
1993	1
1995	1
1996	1
1997	1
1998	1
2001	1
2002	1
2003	1
2004	1
2008	1
2011	1
2012	1
2014	1
2024	0

1

Principles for adoptive T cell therapy of human viral diseases.

Riddell SR, Greenberg PD. Riddell SR, et al. Annu Rev Immunol. 1995;13:545-86. doi: 10.1146/annurev.iy.13.040195.002553. Annu Rev Immunol. 1995. PMID: 7612234 Review.

2

Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.

Greenberg PD. Greenberg PD. Adv Immunol. 1991;49:281-355. doi: 10.1016/s0065-2776(08)60778-6. Adv Immunol. 1991. PMID: 1853786 Review. No abstract available.

3

Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells.

Wölfl M, Greenberg PD. Wölfl M, et al. Nat Protoc. 2014 Apr;9(4):950-66. doi: 10.1038/nprot.2014.064. Epub 2014 Mar 27. Nat Protoc. 2014. PMID: 24675735 Free PMC article.

4

Potential uses of interleukin 2 in cancer therapy.

Cheever MA, Thompson JA, Peace DJ, Greenberg PD. Cheever MA, et al. Immunobiology. 1986 Sep;172(3-5):365-82. doi: 10.1016/S0171-2985(86)80118-8. Immunobiology. 1986. PMID: 3492434

5

FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.

Klarnet JP, Kern DE, Okuno K, Holt C, Lilly F, Greenberg PD. Klarnet JP, et al. J Exp Med. 1989 Feb 1;169(2):457-67. doi: 10.1084/jem.169.2.457. J Exp Med. 1989. PMID: 2562982 Free PMC article.

6

CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function.

Ohlén C, Kalos M, Cheng LE, Shur AC, Hong DJ, Carson BD, Kokot NC, Lerner CG, Sather BD, Huseby ES, Greenberg PD. Ohlén C, et al. J Exp Med. 2002 Jun 3;195(11):1407-18. doi: 10.1084/jem.20011063. J Exp Med. 2002. PMID: 12045239 Free PMC article.

7

In vivo administration of interleukin-2.

Cheever MA, Greenberg PD. Cheever MA, et al. Contemp Top Mol Immunol. 1985;10:263-82. doi: 10.1007/978-1-4684-4838-2_11. Contemp Top Mol Immunol. 1985. PMID: 3884257 Review. No abstract available.

8

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.

Greenberg PD, Kern DE, Cheever MA. Greenberg PD, et al. J Exp Med. 1985 May 1;161(5):1122-34. doi: 10.1084/jem.161.5.1122. J Exp Med. 1985. PMID: 3921652 Free PMC article.

9

Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia.

Peace DJ, Cheever MA. Peace DJ, et al. J Exp Med. 1989 Jan 1;169(1):161-73. doi: 10.1084/jem.169.1.161. J Exp Med. 1989. PMID: 2783332 Free PMC article.

10

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.

Cheever MA, Thompson DB, Klarnet JP, Greenberg PD. Cheever MA, et al. J Exp Med. 1986 May 1;163(5):1100-12. doi: 10.1084/jem.163.5.1100. J Exp Med. 1986. PMID: 3084700 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year